HHS seeks to toss drug pricing suit on IRA anniversary

On the first anniversary of the Inflation Reduction Act, the Biden administration is defending its authority to negotiate drug prices through Medicare as the Department of Health and Human Services filed a motion to dismiss a lawsuit by the U.S. Chamber of Commerce challenging HHS new price-setting powers under the IRA. Host Alice Miranda Ollstein talks with Lauren Gardner about the legal challenges facing the administration’s efforts to lower prescription drug costs.